- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05413590
Description of Physical Activity Effect on Neuromuscular Fatigue of Older People (ACTIFS-AGE)
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: LEONARD FEASSON, PHD
- Phone Number: +33 04 77 12 03 83
- Email: leonard.feasson@chu-st-etienne.fr
Study Contact Backup
- Name: DIANA RIMAUD
- Phone Number: +33 04 77 12 04 67
- Email: diana.rimaud@chu-st-etienne.fr
Study Locations
-
-
-
Saint-Étienne, France, 42055
- Recruiting
- Chu de Saint-Etienne
-
Sub-Investigator:
- David HUPIN, MD
-
Sub-Investigator:
- Clément FOSCHIA, MD
-
Sub-Investigator:
- Philippe BOIRON, MD
-
Principal Investigator:
- Léonard FEASSON, MD PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged 18 to 35 for the young group, between 65 and 80 for the old group and over 80 for the very old group.
- Signed consent for the study obtained
- Subject affiliated or entitled to a social security scheme
Exclusion Criteria:
- Pathology or surgical intervention causing a locomotor disorder
- Neurological, cardiovascular or psychological pathology
- Participants will be excluded if resting or exercise ECG responses show any abnormality, or if resting Heart Rate (HR) > 100 bmp, resting blood pressure > 144 (systolic) / 95 (diastolic) mmHg, pulmonary and or cardiac disease that could affect the health of the participant (arrhythmias and stroke)
- Mini-Mental State Examination score < 20 (>80 years old)
- Significant change in the amount of physical practice over the last 5 years.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Young, Active group
From 18 to 35 years old. The subjects will be considered as active if after completion of the Global Physical Activity Questionnaire (GPAQ), the subjects count:
|
Cognitive tests, completing questionnaires, balance test, measuring cardiac variability and post-ischemic hyperemia.
Assessments of neuromuscular function on a semi-recumbent ergometric bicycle.
Measurement of the maximum isometric forces of the knee flexors, the plantar flexors of the ankle and the grip strength of the hand.
Measurement of feet pressure and measurement of the energy cost.
Maximum test on an endocycle (classic) to determine VO2max.
|
|
Active Comparator: Young, sedentary group
From 18 to 35 years old.
Subjects who are below these thresholds will be considered as sedentary.
To avoid including a subject who recently changed his lifestyle (sedentary becoming active or vice versa), the investigator will ensure the subject kept this physical activity level (expressed using the GPAQ) constant for the last 5 years.
|
Cognitive tests, completing questionnaires, balance test, measuring cardiac variability and post-ischemic hyperemia.
Assessments of neuromuscular function on a semi-recumbent ergometric bicycle.
Measurement of the maximum isometric forces of the knee flexors, the plantar flexors of the ankle and the grip strength of the hand.
Measurement of feet pressure and measurement of the energy cost.
Maximum test on an endocycle (classic) to determine VO2max.
|
|
Active Comparator: Old, Active group
From 65 to 80 years old. The subjects will be considered as active if after completion of the Global Physical Activity Questionnaire (GPAQ), the subjects count:
|
Cognitive tests, completing questionnaires, balance test, measuring cardiac variability and post-ischemic hyperemia.
Assessments of neuromuscular function on a semi-recumbent ergometric bicycle.
Measurement of the maximum isometric forces of the knee flexors, the plantar flexors of the ankle and the grip strength of the hand.
Measurement of feet pressure and measurement of the energy cost.
Maximum test on an endocycle (classic) to determine VO2max.
|
|
Active Comparator: Old sedentary group
From 65 to 80 years old.
Subjects who are below these thresholds will be considered as sedentary.
To avoid including a subject who recently changed his lifestyle (sedentary becoming active or vice versa), the investigator will ensure the subject kept this physical activity level (expressed using the GPAQ) constant for the last 5 years.
|
Cognitive tests, completing questionnaires, balance test, measuring cardiac variability and post-ischemic hyperemia.
Assessments of neuromuscular function on a semi-recumbent ergometric bicycle.
Measurement of the maximum isometric forces of the knee flexors, the plantar flexors of the ankle and the grip strength of the hand.
Measurement of feet pressure and measurement of the energy cost.
Maximum test on an endocycle (classic) to determine VO2max.
|
|
Active Comparator: Very old, Active group
From 81 years old. The subjects will be considered as active if after completion of the Global Physical Activity Questionnaire (GPAQ), the subjects count:
|
Cognitive tests, completing questionnaires, balance test, measuring cardiac variability and post-ischemic hyperemia.
Assessments of neuromuscular function on a semi-recumbent ergometric bicycle.
Measurement of the maximum isometric forces of the knee flexors, the plantar flexors of the ankle and the grip strength of the hand.
Measurement of feet pressure and measurement of the energy cost.
Maximum test on an endocycle (classic) to determine VO2max.
|
|
Active Comparator: Very old sedentary group
From 81 years old.
Subjects who are below these thresholds will be considered as sedentary.
To avoid including a subject who recently changed his lifestyle (sedentary becoming active or vice versa), the investigator will ensure the subject kept this physical activity level (expressed using the GPAQ) constant for the last 5 years.
|
Cognitive tests, completing questionnaires, balance test, measuring cardiac variability and post-ischemic hyperemia.
Assessments of neuromuscular function on a semi-recumbent ergometric bicycle.
Measurement of the maximum isometric forces of the knee flexors, the plantar flexors of the ankle and the grip strength of the hand.
Measurement of feet pressure and measurement of the energy cost.
Maximum test on an endocycle (classic) to determine VO2max.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maximal voluntary contraction (MVC) of the knee extensor muscle measurement
Time Frame: At 48 hours
|
Maximal isometric force (maximal voluntary contraction, MVC) of the knee extensor muscle measured before and after an incremental test on a bicycle ergometer
|
At 48 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Voluntary activation measurement (%)
Time Frame: At 48 hours
|
The level of voluntary activation will be determined by the force increment obtained following stimulation performed during a condition of the muscle in a state of maximum contraction.
|
At 48 hours
|
|
Maximal voluntary contraction (MVC) of the plantar flexor muscle measurement
Time Frame: At 48 hours
|
Maximal isometric force (maximal voluntary contraction, MVC) of the knee extensor muscle measured before and after an incremental test on a bicycle ergometer
|
At 48 hours
|
|
Maximal voluntary contraction (MVC) of the hand grip measurement
Time Frame: At 48 hours
|
Maximal isometric force (maximal voluntary contraction, MVC) of the knee extensor muscle measured before and after an incremental test on a bicycle ergometer
|
At 48 hours
|
|
Cardiac variability(ms)
Time Frame: At 48 hours
|
24-hour measurement with an ECG holter for 24 hours.
|
At 48 hours
|
|
Muscle oxygenation (%)
Time Frame: At 48 hours
|
This is measured by a NIRS20 (near infrared spectroscopy, Oxysoft, Artinis, TheNetherlands)
|
At 48 hours
|
|
Balance test (s)
Time Frame: At 48 hours
|
This test, performed in unipedal support, consists of asking the subject to hold the unipedal position for as long as possible, on the lower limb of his choice.
|
At 48 hours
|
|
Test of Get-up-and-Go (s)
Time Frame: At 48 hours
|
For test of Get-up-and-Go, participants will be asked to stand from a seated position, walk 3 meters at their usual pace, turn around, walk back to the chair, and sit down. Measured in seconds when performing test. |
At 48 hours
|
|
Reaction force on the ground for each step (N)
Time Frame: At 72 hours
|
First, a maximum pace walking speed and a comfort speed will be measured in a corridor using photoelectric cells.
Then, a biomechanical analysis of walking at several speeds (comfort walking, 2.5, 4 and 5.5 km/h) will be performed on an instrumented treadmill (Treadmetrix, Park City, Utah, United States).
This treadmill allows the analysis of the reaction forces on the ground during the strides while controlling the speed of the walk.
Each step will last approximately 30 seconds.
|
At 72 hours
|
|
Maximal oxygen consumption (VO2max) during an effort test on a cycloergometer
Time Frame: At 72 hours
|
At 72 hours
|
|
|
Functional Assessment of Chronic Illness Therapy (FACIT) questionnaire
Time Frame: At inclusion
|
Score from 0 to 52
|
At inclusion
|
|
Quality of life via the SF-36 questionnaire
Time Frame: At inclusion
|
This questionnaire is composed of 12 questions representing the eight most relevant domains to describe and evaluate quality of life.
Score ranges from 0 to 100, with a higher score defining a more favorable health state.
|
At inclusion
|
Collaborators and Investigators
Investigators
- Principal Investigator: LEONARD FEASSON, PHD, Centre Hospitalier Universitaire de Saint Etienne
- Study Chair: Guillaume MILLET, PhD, UNIVERSITE DE SAINT ETIENNE
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21CH033
- ANSM (Other Identifier: 2025-A02220-49)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fatigue
-
National Taiwan Sport UniversityGrape King Bio Ltd.CompletedEffect of Lactobacillus Plantarum GKK1 Supplementation on Anti-fatigue Health Effects (GKK1-Fatigue)Muscle Fatigue | Sports Performance | Exercise-Induced Fatigue | Fatigue RecoveryTaiwan
-
Bakulev Scientific Center of Cardiovascular SurgeryFoundation for the Support of Physical Culture and Sports BECOME A CHAMPION; Autonomous Non-Profit organization of additional education sports school BECOME A CHAMPIONRecruitingEfficacy, Self | Fatigue, Mental | Fatigue; Muscle, Heart | Fatigue; CombatRussian Federation
-
University of Southern MississippiEnrolling by invitationFatigue, Mental | Fatigue; Muscle, HeartUnited States
-
Akdeniz UniversityCompletedExercise-Induced Fatigue | Forearm Muscle FatigueTurkey (Türkiye)
-
Universita di VeronaUniversity of Southern CaliforniaCompletedDiet, Healthy | Fasting | Fatigue, Mental | Fatigue; Muscle, HeartItaly
-
Istinye UniversityRecruitingMental Fatigue | Muscular FatigueTurkey (Türkiye)
-
Chengdu Sport UniversityNot yet recruiting
-
University of ZurichCompletedVocal FatigueSwitzerland
-
KU LeuvenCompleted
-
Société des Produits Nestlé (SPN)Maastricht University Medical CenterCompleted
Clinical Trials on Questionnaires completion
-
University Hospital, GrenobleNot yet recruiting
-
Centre Hospitalier Universitaire de BesanconCentre Hospitalier Universitaire Dijon; Centre Hospitalier de l'Agglomération... and other collaboratorsCompleted
-
ElsanNot yet recruitingEndometriosis | Obstructive Sleep Apnea-hypopnea
-
European Institute of OncologyRecruiting
-
European Institute of OncologyActive, not recruitingBreast Cancer | Endocrine Breast DiseasesItaly
-
University Hospital, ToulouseRecruitingHead and Neck CancerFrance
-
University Hospital, MontpellierCompleted
-
Tools4PatientCompletedBone MetastasisBelgium, France
-
University Paris 7 - Denis DiderotUniversity of Manchester; Hospital Vall d'Hebron; Hôpital Louis Mourier; EA 7334...CompletedIBS - Irritable Bowel Syndrome | General PopulationUnited Kingdom, France, Spain
-
Women's Hospital School Of Medicine Zhejiang UniversityNot yet recruitingFertility Disorders | Assisted Reproductive Technology | Offspring Health